Key challenges faced by a PK/PD scientist will be addressed and approaches to overcome the challenges will be demonstrated. One would also learn about: (a) the use of PK/PD principles to overcome biological barriers e.g. BBB (b) effective translation of preclinical data into the clinic (c) utilization of PK/PD analysis and modeling to identify and validate appropriate biomarkers (d) perspective of the regulatory authorities regarding the use of PK/PD in streamlining the drug development (e) FIH dose prediction to achieve maximum efficacy and reduce the toxicity (f) development and utilization of systems pharmacology model to integrate known molecular pathways to validate drug targets.
The conference will be a very valuable tool for preclinical or clinical scientists and managers, working in the field of PK/PD, who are striving to use the PK/PD principles to minimize drug development risk and maximize clinical success. The sessions for our 2012 agenda are shown below.
More about the Event